4.6 Review

Cancer microRNAs: From subtype profiling to predictors of response to therapy

期刊

TRENDS IN MOLECULAR MEDICINE
卷 17, 期 5, 页码 235-243

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2011.01.008

关键词

-

资金

  1. NCI NIH HHS [K08 CA124484-01A1, R01 CA131301, R01 CA131301-01A1, K08 CA124484] Funding Source: Medline

向作者/读者索取更多资源

MicroRNAs (miRNAs) are key regulators of gene expression that regulate important oncogenes and tumor suppressors. Many miRNAs can also act as oncogenes or tumor suppressors, and thus the altered expression of miRNAs is a hallmark of many cancer types. Dysregulated miRNAs provide a potentially powerful new tool that could be used to enable the characterization of tumor environments and identify novel and important oncogenic pathways. More recently, there has been growing interest in the field of miRNAs as biomarkers of cancer risk, diagnosis and response to therapy. Understanding the associations between miRNA expression and cancer phenotypes, and the potential of miRNA profiling in clinical applications, promises to be highly rewarding in the field of cancer research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pathology

MicroRNA signatures discriminate between uterine and ovarian serous carcinomas

Pei Hui, Stefan M. Gysler, Mohamed Uduman, Taiwo A. Togun, Daniel E. Prado, Christine E. Brambs, Sunitha Nallur, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Santin, Joanne B. Weidhaas, Elena S. Ratner

HUMAN PATHOLOGY (2018)

Article Oncology

A germline mutation in the BRCA1 3′UTR predicts Stage IV breast cancer

Jemima J. Dorairaj, David W. Salzman, Deirdre Wall, Tiffany Rounds, Carina Preskill, Catherine A. W. Sullivan, Robert Lindner, Catherine Curran, Kim Lezon-Geyda, Terri McVeigh, Lyndsay Harris, John Newell, Michael J. Kerin, Marie Wood, Nicola Miller, Joanne B. Weidhaas

BMC CANCER (2014)

Article Biochemistry & Molecular Biology

Structured and disordered facets of the GPCR fold

A. J. Venkatakrishnan, Tilman Flock, Daniel Estevez Prado, Matt E. Oates, Julian Gough, M. Madan Babu

CURRENT OPINION IN STRUCTURAL BIOLOGY (2014)

Review Oncology

Radiation Therapy Oncology Group Gynecologic Oncology Working Group Comprehensive Results

David K. Gaffney, Anuja Jhingran, Lorraine Portelance, Akila Viswanathan, Tracey Schefter, Joanne Weidhaas, William Small

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)

Article Oncology

Current Status and Recommendations for the Future of Research, Teaching, and Testing in the Biological Sciences of Radiation Oncology: Report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, Executive Summary

Paul E. Wallner, Mitchell S. Anscher, Christopher A. Barker, Michael Bassetti, Robert G. Bristow, Yong I. Cha, Adam P. Dicker, Silvia C. Formenti, Edward E. Graves, Stephen M. Hahn, Tom K. Hei, Alec C. Kimmelman, David G. Kirsch, Kevin R. Kozak, Theodore S. Lawrence, Brian Marples, William H. McBride, Ross B. Mikkelsen, Catherine C. Park, Joanne B. Weidhaas, Anthony L. Zietman, Michael Steinberg

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

Article Biochemistry & Molecular Biology

Tumor-associated mutations in a conserved structural motif alter physical and biochemical properties of human RAD51 recombinase

Jianhong Chen, Milagros D. Morrical, Katherine A. Donigan, Joanne B. Weidhaas, Joann B. Sweasy, April M. Averill, Jennifer A. Tomczak, Scott W. Morrical

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemistry & Molecular Biology

Targeted resequencing of the microRNAome and 3′UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer

X. Chen, T. Paranjape, C. Stahlhut, T. McVeigh, F. Keane, S. Nallur, N. Miller, M. Kerin, Y. Deng, X. Yao, H. Zhao, J. B. Weidhaas, F. J. Slack

ONCOGENE (2015)

Article Multidisciplinary Sciences

The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Trials 9708 and 9905

Larissa J. Lee, Elena Ratner, Mohamed Uduman, Kathryn Winter, Marta Boeke, Kathryn M. Greven, Stephanie King, Thomas W. Burke, Kelly Underhill, Harold Kim, Raleigh J. Boulware, Herbert Yu, Vinita Parkash, Lingeng Lu, David Gaffney, Adam P. Dicker, Joanne Weidhaas

PLOS ONE (2014)

Review Oncology

Functional microRNA binding site variants

Ye Yuan, Joanne B. Weidhaas

MOLECULAR ONCOLOGY (2019)

Article Oncology

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy

Joanne Weidhaas, Nicholas Marco, Aaron W. Scheffler, Anusha Kalbasi, Kirk Wilenius, Emily Rietdorf, Jaya Gill, Mara Heilig, Caroline Desler, Robert K. Chin, Tania Kaprealian, Susan McCloskey, Ann Raldow, Naga P. Raja, Santosh Kesari, Jose Carrillo, Alexandra Drakaki, Mark Scholz, Donatello Telesca

Summary: The study found that a germline microRNA-based biomarker signature can accurately predict grade 2 and higher immune-related adverse effects (irAEs) to anti-PD1/PDL1 therapy in a pan-cancer manner. RAC1 was identified as a significant biomarker of toxicity, predicting a greater than ninefold increased risk of toxicity, but was not associated with response to anti-PD1/PDL1 therapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial

Amar U. Kishan, Nicholas Marco, Ting Martin Ma, Michael L. Steinberg, Ankush Sachdeva, Minsong Cao, Leslie K. Ballas, Emily Rietdorf, Donatello Telesca, Joanne B. Weidhaas

Summary: The predictors of genitourinary toxicity after post-prostatectomy radiotherapy are still unknown. A previously defined germline DNA signature (PROSTOX) has shown to be able to predict late grade>=2 genitourinary toxicity after intact prostate stereotactic body radiotherapy. We investigate whether PROSTOX can predict toxicity among patients receiving post-prostatectomy SBRT in a phase II clinical trial.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Oncology

Prediction of Radiation Treatment Response for Locally Advanced Rectal Cancer via a Longitudinal Trend Analysis Framework on Cone-Beam CT

Zirong Li, Ann C. Raldow, Joanne B. Weidhaas, Qichao Zhou, X. Sharon Qi

Summary: Locally advanced rectal cancer (LARC) presents a challenge in terms of identifying individualized response to radiation therapy. This study proposes a framework using CBCT scans for accurate and robust assessment of treatment response, allowing for early detection and monitoring of patient response.

CANCERS (2023)

Article Oncology

The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC

Joanne B. Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein, Joe Y. Chang, Bo Lu, Adam P. Dicker, Jeffrey A. Bogart, Yolanda I. Garces, Samir Narayan, Clifford G. Robinson, Vivek S. Kavadi, Joel S. Greenberger, Christopher D. Koprowski, James Welsh, Elizabeth M. Gore, Robert M. Macrae, Rebecca Paulus, Jeffrey D. Bradley

Summary: Although overall survival advantage was not observed in KRAS-variant patients, there is a potential impact of cetuximab for this genetic subset of patients. In contrast, cetuximab seems to harm non-variant patients. These findings further support the importance of genetic patient selection in trials studying the addition of systemic agents to radiotherapy.

CANCER RESEARCH COMMUNICATIONS (2023)

Review Biochemistry & Molecular Biology

Breast Cancer and miR-SNPs: The Importance of miR Germ-Line Genetics

Poonam Malhotra, Graham H. Read, Joanne B. Weidhaas

NON-CODING RNA (2019)

Meeting Abstract Biochemistry & Molecular Biology

Trade-off between GPCR folding and functional versatility

Daniel Estevez Prado, Tilman Flock, Alexander S. Hauser, Ramanujan S. Hegde, M. Madan Babu

PROTEIN SCIENCE (2017)

暂无数据